BioSpace News Archive

Titan Pharmaceuticals, Inc. announced that it has two poster presentations on Probuphine implant, Titan’s novel 6-month maintenance treatment for Opioid Use Disorder in eligible patients, at the 10th American Conference on Pharmacometrics taking place on October 20-23, 2019 in Orlando, FL..

HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress.

2019 Third Quarter Diluted EPS of $0.23; Adjusted Diluted EPS of $0.96

Centene Corporation and WellCare Health Plans, Inc. announced that the New York Department of Financial Services and Department of Health have each approved Centene’s pending indirect acquisition of New York domiciled WellCare insurance subsidiaries, bringing the total number of states to approve the transaction to 25..

Boston Scientific Corporation announced the commencement of a cash tender offer for up to $1.0 billion aggregate principal amount of the outstanding senior notes listed in the table below

Neurotechnology’s template generator and matcher top the NIST MINEX, ranking as the most interoperable and accurate fingerprint recognition system

Maxar extends its leadership in nimble robotics by delivering its sixth robotic arm that will be used on Mars

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, announced financial results for the third quarter ended September 30, 2019, and provided a business update.

ImmuneCyte to Begin Operations in Fourth Quarter of 2019

Rhizen Pharmaceuticals S.A. announces poster presentation of RP4010, a novel first-in-class SOCE inhibitor in preclinical models of Acute Myeloid Leukemia.